Gamunex Related Clinical Trials
A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency [Active, not recruiting]
Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent Miscarriage [Active, not recruiting]
Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage [Recruiting]
Intravenous Immunoglobulin After Relapse in Vasculitis [Terminated]
Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Completed]
Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease [Active, not recruiting]
Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults [Recruiting]
Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) [Completed]
Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins [Recruiting]
Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients [Completed]
Efficacy of High-Dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease [Recruiting]
Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Completed]
High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration [Completed]
Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP [Completed]
Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis [Completed]
Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration [Completed]
Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea [Recruiting]
Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10% [Completed]
A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP. [Recruiting]
Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS) [Completed]
Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract [Recruiting]
Intravenous Immunoglobulin (IVIG) in Lung Transplantation [Recruiting]
Preventing Intravenous Immunoglobulin-Associated Adverse Reactions [Recruiting]
Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia) [Completed]
The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants [Terminated]
Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease [Not yet recruiting]
IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load [Recruiting]
Preventive IVIG Therapy for Congenital Heart Block [Recruiting]
Treatment of Sickle Cell Pain Crises With High-Dose Intravenous Gammaglobulin [Recruiting]
Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients [Completed]
Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy [Active, not recruiting]
Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy [Completed]
Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg) [Completed]
IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff [Completed]
Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis [Completed]
Intravenous Immunoglobulin Therapy in Optic Neuritis [Completed]
Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis [Active, not recruiting]
Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy [Active, not recruiting]
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy [Completed]
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis [Active, not recruiting]
Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) [Terminated]
Treatment of Deficient Subclass or Anti-Polysaccharide Antibody Response [Recruiting]
Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies [Completed]
Efficacy and Safety Study of GB-0998 for Treatment of Steroid-Resistant Polymyositis and Dermatomyositis (PM/DM) [Recruiting]
Omr-IgG-am™ (Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease [Active, not recruiting]
Efficacy of Tacrolimus and i.v.-Immunoglobulins in Rasmussen Encephalitis [Recruiting]
Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections [Completed]
Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. [Completed]
Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer [Active, not recruiting]
Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10
Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders [Completed]
Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)
Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients [Recruiting]
Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis [Recruiting]
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma [Recruiting]
Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction [Recruiting]
Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura [Completed]
Study of CIDP Patients During IVIG Treatment [Completed]
Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients [Completed]
An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens [Completed]
A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Recruiting]
Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy [Recruiting]
Effect of Intravenous Immunglobulin (IVIG) After Myocardial Infarction [Not yet recruiting]
IVIG - West Nile Encephalitis: Safety and Efficacy [No longer recruiting]
A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia [Recruiting]
Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis [Recruiting]
Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis [Recruiting]
IGIV Study for Chronic ITP Patients Ages 3-70 [Recruiting]
Efficacy and Safety of IVIG-L in ITP Patients [Completed]
A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria [Completed]
Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients [Recruiting]
Collection of Convalescent SARS Plasma by Apheresis [Completed]
A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
Molecular and Clinical Studies of Primary Immunodeficiency Diseases [Recruiting]
Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects [Recruiting]
|
